Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; 'Back to Top' removed—a minor UI cleanup with no substantive content changes.
    Difference
    0.4%
    Check dated 2025-09-14T00:24:42.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.4%
    Check dated 2025-09-06T21:08:25.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's content.
    Difference
    100%
    Check dated 2025-08-30T15:32:36.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.11 to v2.16.12, and the date has changed from 2025-07-18 to 2025-08-15.
    Difference
    0.9%
    Check dated 2025-08-16T12:06:11.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T07:43:21.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T04:03:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.